Mirae Asset Global Investments’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27.7K | Sell |
2,312
-328
| -12% | -$2.72K | ﹤0.01% | 1452 |
|
|
2026
Q1 | $22.1K | Buy |
2,640
+180
| +7% | +$1.89K | ﹤0.01% | 1419 |
|
|
2025
Q4 | $35.4K | Buy |
2,460
+507
| +26% | +$6.32K | ﹤0.01% | 1464 |
|
|
2025
Q3 | $18.8K | Buy |
1,953
+15
| +0.8% | +$133 | ﹤0.01% | 1506 |
|
|
2025
Q2 | $15.9K | Buy |
1,938
+307
| +19% | +$2.57K | ﹤0.01% | 1427 |
|
|
2025
Q1 | $12.8K | Sell |
1,631
-20
| -1% | -$149 | ﹤0.01% | 1446 |
|
|
2024
Q4 | $12.2K | Sell |
1,651
-137
| -8% | -$1.29K | ﹤0.01% | 1490 |
|
|
2024
Q3 | $19.3K | Buy |
1,788
+317
| +22% | +$3.86K | ﹤0.01% | 1439 |
|
|
2024
Q2 | $17.1K | Sell |
1,471
-168,747
| -99% | -$2.63M | ﹤0.01% | 1403 |
|
|
2024
Q1 | $3.22M | Buy |
170,218
+75,800
| +80% | +$1.35M | 0.01% | 1011 |
|
|
2023
Q4 | $1.69M | Sell |
94,418
-113,889
| -55% | -$2.01M | ﹤0.01% | 1334 |
|
|
2023
Q3 | $3.43M | Buy |
208,307
+15,794
| +8% | +$286K | 0.01% | 973 |
|
|
2023
Q2 | $3.85M | Buy |
192,513
+21,799
| +13% | +$420K | 0.01% | 961 |
|
|
2023
Q1 | $3.23M | Buy |
170,714
+6,229
| +4% | +$138K | 0.01% | 990 |
|
|
2022
Q4 | $3.73M | Sell |
164,485
-25,225
| -13% | -$570K | 0.01% | 912 |
|
|
2022
Q3 | $5.01M | Buy |
189,710
+24,885
| +15% | +$738K | 0.01% | 802 |
|
|
2022
Q2 | $4.07M | Buy |
164,825
+48,879
| +42% | +$1.22M | 0.01% | 904 |
|
|
2022
Q1 | $3.85M | Sell |
115,946
-21,465
| -16% | -$596K | 0.01% | 955 |
|
|
2021
Q4 | $4.49M | Buy |
137,411
+26,898
| +24% | +$916K | 0.01% | 910 |
|
|
2021
Q3 | $4.63M | Buy |
110,513
+21,833
| +25% | +$786K | 0.01% | 863 |
|
|
2021
Q2 | $3.44M | Buy |
88,680
+12,035
| +16% | +$430K | 0.01% | 918 |
|
|
2021
Q1 | $2.61M | Buy |
76,645
+34,801
| +83% | +$1.48M | 0.01% | 898 |
|
|
2020
Q4 | $1.9M | Buy |
41,844
+9,042
| +28% | +$316K | 0.01% | 947 |
|
|
2020
Q3 | $903K | Buy |
32,802
+10,241
| +45% | +$334K | ﹤0.01% | 1006 |
|
|
2020
Q2 | $831K | Buy |
22,561
+8,701
| +63% | +$324K | 0.01% | 961 |
|
|
2020
Q1 | $449K | Buy |
13,860
+1,514
| +12% | +$63.1K | ﹤0.01% | 1057 |
|
|
2019
Q4 | $506K | Buy |
12,346
+1,008
| +9% | +$39.8K | ﹤0.01% | 1219 |
|
|
2019
Q3 | $403K | Buy |
+11,338
| New | +$459K | ﹤0.01% | 1236 |
|
|
2018
Q1 | – | Sell |
-54,003
| Closed | -$1.79M | – | 760 |
|
|
2017
Q4 | $1.79M | Sell |
54,003
-1,837
| -3% | -$55.3K | 0.02% | 372 |
|
|
2017
Q3 | $1.84M | Sell |
55,840
-62,251
| -53% | -$1.4M | 0.03% | 342 |
|
|
2017
Q2 | $2.33M | Buy |
118,091
+42,500
| +56% | +$823K | 0.04% | 274 |
|
|
2017
Q1 | $1.46M | Buy |
75,591
+51,802
| +218% | +$999K | 0.03% | 326 |
|
|
2016
Q4 | $441K | Sell |
23,789
-59,611
| -71% | -$1.14M | 0.01% | 412 |
|
|
2016
Q3 | $1.17M | Buy |
+83,400
| New | +$920K | 0.02% | 328 |
|
Other funds holding RGNX
YIH
Mirae Asset Global Investments's RGNX Position: Q2 2026 in Review
Mirae Asset Global Investments reduced its Regenxbio (RGNX) stake by 12% in Q2 2026, selling an estimated $2.72K and leaving 2,312 shares worth $27.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1452.
Mirae Asset Global Investments first reported a position in RGNX in Q3 2016 and has held it in 34 quarters since. The position peaked at $5.01M in Q3 2022. 52 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.
- Mirae Asset Global Investments held 2,312 shares of Regenxbio worth $27.7K as of Q2 2026.
- Mirae Asset Global Investments sold 328 Regenxbio shares in Q2 2026, an estimated $2.72K.
- Regenxbio made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1452 holding.
- Mirae Asset Global Investments first reported a position in Regenxbio in Q3 2016 and has held it in 34 quarters since.
- Mirae Asset Global Investments's Regenxbio position peaked at $5.01M in Q3 2022.
- 52 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.
Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.